identification gene vitamin k epoxide reductase
vitamin k epoxide reductase vkor target warfarin widely prescribed anticoagulant thromboembolic disorders although estimated prevent twenty strokes per induced bleeding episode warfarin under-used difficulty controlling dosage fear inducing bleeding although identified ref enzyme yet purified gene identified positional cloning approach become possible mapping warfarin resistance rat chromosome ref vitamin k-dependent protein deficiencies syntenic region human chromosome ref localization vkor genes within human chromosome 16p12-q21 narrowed search genes encoding candidate transmembrane proteins used short interfering rna sirna pools individual genes test ability inhibit vkor activity human cells report identification gene vkor based specific inhibition vkor activity single sirna pool confirmed mgc11276 messenger rna encodes vkor expression insect cells sensitivity warfarin expressed enzyme amino acids long least one transmembrane domain identification vkor gene extends understanding blood clotting facilitate development new anticoagulant drugs
